Drug Type Monoclonal antibody |
Synonyms BCG 004, BCG004 |
Target |
Action inhibitors |
Mechanism Rabies virus protein inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Infectious Diseases | Preclinical | China | 26 Feb 2024 |






